A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of Schizophrenia

NCT00350467 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

288

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Schizophrenia

Interventions

DRUG: ER OROS paliperidone and Olanzapine

Sponsor

Xian-Janssen Pharmaceutical Ltd.